Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-02-28 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Shares withheld for taxes −188 $284.75 $54K 9,147.86
2017-02-28 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Shares withheld for taxes −727 $274.76 $200K 8,420.86
2017-02-28 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Exercise or conversion +1,569 9,989.86
2017-02-28 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Shares withheld for taxes −739 $274.76 $203K 9,250.86
2017-02-28 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Exercise or conversion +628 9,878.86
2017-02-28 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Shares withheld for taxes −296 $274.60 $81K 9,582.86
2017-02-28 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Exercise or conversion +815 10,397.86
2017-02-28 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Shares withheld for taxes −384 $274.76 $106K 10,013.86
2017-02-28 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Other disposition · Restricted Stock Unit −1,841 8,397
2017-02-28 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Other disposition · Restricted Stock Unit −738 628
2017-02-28 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Other disposition · Restricted Stock Unit −1,103 6,335
2017-02-28 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Other disposition · Restricted Stock Unit −662 1,460
2017-02-28 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Exercise or conversion · Restricted Stock Unit −1,375 4,960
2017-02-28 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Exercise or conversion · Restricted Stock Unit −398 1,062
2017-02-28 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Exercise or conversion · Restricted Stock Unit −1,569 6,828
2017-02-28 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Exercise or conversion · Restricted Stock Unit −628 0
2017-02-28 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Exercise or conversion · Restricted Stock Unit −815 0
2017-02-28 ALEXANDER SUSAN H EVP, Chief Legal Officer Exercise or conversion +728 32,568
2017-02-28 ALEXANDER SUSAN H EVP, Chief Legal Officer Shares withheld for taxes −335 $284.75 $95K 32,233
2017-02-28 ALEXANDER SUSAN H EVP, Chief Legal Officer Exercise or conversion +1,375 33,608

Page 64 of 73 · 1,456 trades